0.5387
-0.0265
(-4.69%)
At close: January 10 at 4:00:02 PM EST
0.6000
+0.06
+(11.38%)
After hours: January 10 at 7:02:56 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.32M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| QUINN WILLIAM P Chief Financial Officer | Purchase at price 0.78 - 1.62 per share. | Direct | 12,043 | Dec 12, 2023 |
| YONEHIRO GRANT Officer | Purchase at price 0.78 per share. | Direct | 1,955 | Dec 6, 2023 |
| PEREZ EDITH A Officer | Purchase at price 0.78 - 1.62 per share. | Direct | 5,308 | Dec 6, 2023 |
| ENGLEMAN EDGAR G. M.D. Director | Sale at price 0.86 - 0.91 per share. | Indirect | 128,993 | Nov 30, 2023 |
| ENGLEMAN EDGAR G. M.D. Director | Sale at price 0.90 per share. | Indirect | 1,751 | Nov 21, 2023 |
| VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.90 per share. | Indirect | 3,060 | Nov 21, 2023 |
| ENGLEMAN EDGAR G. M.D. Director | Sale at price 0.92 - 0.96 per share. | Indirect | 45,675 | Nov 20, 2023 |
| VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.92 - 0.96 per share. | Indirect | 79,933 | Nov 20, 2023 |
| YONEHIRO GRANT Officer | Purchase at price 1.18 - 1.64 per share. | Direct | 7,055 | Dec 6, 2022 |
| SCHATZMAN RANDALL C Chief Executive Officer | Purchase at price 1.18 - 1.64 per share. | Direct | 7,055 | Dec 6, 2022 |
| QUINN WILLIAM P Chief Financial Officer | Purchase at price 1.18 - 1.64 per share. | Direct | 6,215 | Dec 6, 2022 |
| PEREZ EDITH A Officer | Purchase at price 1.18 - 1.64 per share. | Direct | 7,055 | Dec 6, 2022 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.00 per share. | Direct | 1,600,000 | Jul 13, 2022 |
| PEREZ EDITH A Officer | Conversion of Exercise of derivative security at price 2.80 per share. | Direct | 99,999 | Dec 22, 2021 |
| QUINN WILLIAM P Chief Financial Officer | Purchase at price 4.71 per share. | Direct | 23,575 | Dec 8, 2021 |
| PEREZ EDITH A Officer | Purchase at price 4.64 - 16.65 per share. | Direct | 17,175 | Dec 6, 2021 |
| ENGLEMAN EDGAR G. M.D. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 32.60 per share. | Indirect | 6,520,000 | Feb 9, 2021 |
| ENGLEMAN EDGAR G. M.D. Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.60 per share. | Indirect | 5,346 | Feb 9, 2021 |
| ENGLEMAN EDGAR G. M.D. Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.07 per share. | Indirect | 3,263 | Feb 9, 2021 |
| LAPORTE KATHLEEN D Director | Purchase at price 32.60 per share. | Direct | 39,120 | Feb 9, 2021 |
| SHAH MAHENDRA G Director | Sale at price 33.90 per share. | Indirect | 2,102 | Feb 9, 2021 |
| SHAH MAHENDRA G Director | Conversion of Exercise of derivative security at price 0.07 per share. | Indirect | 1,240 | Feb 9, 2021 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | Purchase at price 33.90 per share. | Direct | 13,560,000 | Feb 9, 2021 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Feb 9, 2021 |
| SCHATZMAN RANDALL C Chief Executive Officer | Purchase at price 32.60 per share. | Direct | 48,900 | Feb 9, 2021 |
| VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 32.60 per share. | Indirect | 11,410,000 | Feb 9, 2021 |
| VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.60 per share. | Indirect | 7,368 | Feb 9, 2021 |
| VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.07 per share. | Indirect | 4,502 | Feb 9, 2021 |
| QUINN WILLIAM P Chief Financial Officer | Purchase at price 32.60 per share. | Direct | 39,120 | Feb 9, 2021 |
| HEALY JAMES I Director | Purchase at price 33.90 per share. | Indirect | 15,255,000 | Feb 9, 2021 |
| HEALY JAMES I Director | -- | Indirect | -- | Feb 9, 2021 |
| SOFINNOVA VENTURE PARTNERS X, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 33.90 per share. | Indirect | 15,255,000 | Feb 9, 2021 |
| SOFINNOVA VENTURE PARTNERS X, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Feb 9, 2021 |
| KHANNA ASHISH SIRI RAM PH.D. Director | Purchase at price 33.90 per share. | Indirect | 74,580 | Feb 9, 2021 |
Related Tickers
ACHL Achilles Therapeutics plc
1.1850
-0.42%
KZR Kezar Life Sciences, Inc.
6.51
-1.06%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
TBPH Theravance Biopharma, Inc.
8.78
-2.98%
OKUR OnKure Therapeutics, Inc.
7.43
-4.87%
NXTC NextCure, Inc.
0.7990
-6.11%
CLRB Cellectar Biosciences, Inc.
0.2823
-9.23%
ASMB Assembly Biosciences, Inc.
15.62
-7.79%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.85%
HLVX HilleVax, Inc.
2.0500
-1.91%